ABOUT US

INVESTORS

Invest in Endless Possibilities

Valeant Pharmaceuticals International, Inc. (NYSE: VRX/TSX: VRX) completed its acquisition of Salix Pharmaceuticals, Ltd. (“Salix”) on April 1, 2015.

To read the latest investor relations news or request additional information, visit Valeant.com.